tetradecanoylphorbol acetate has been researched along with Lung Diseases, Interstitial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buendia-Roldan, I; Chavez-Galan, L; Machahua, C; Molina-Molina, M; Ocaña-Guzman, R; Pardo, A; Selman, M | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Lung Diseases, Interstitial
| Article | Year |
|---|---|
CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile.
Topics: Aged; Aging; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Phenotype; Tetradecanoylphorbol Acetate | 2021 |